The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes.

Novartis AG faces major patent expiries but is buying pipeline assets to sustain growth. Click for this NVS update.

What is SMA? The rare genetic condition that Jesy Nelson’s twin daughters have - Former Little Mix star revealed her twin ...

Leni Forrester, 2, has Sanfilippo Syndrome, a rare genetic condition often described as childhood dementia - and popstar Jesy ...

Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body. It provides an ...